UK National Screening Committee

The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of screening programmes

Role of the group

The UK NSC advises ministers and the NHS in the 4 UK countries about all aspects of screening and supports implementation of screening programmes.


  • Dr David Walker, Chair (University Hospitals of Morecambe Bay Foundation Trust)
  • Dr Hilary Angwin, (Fetal, Maternal and Child Health group)
  • Dr Eric Baija, (NHS Borders)
  • Dr Sunil Bhanot, (General Practitioner)
  • Ms Alison Brown, (Consumer Representative)
  • Professor Roger Brownsword, (King’s College London)
  • Professor Martin Buxton, (Brunel University)
  • Professor Alan Cameron, (The Queen Mother’s Hospital)
  • Professor D Gareth R Evans, (St Mary’s Hospital)
  • Ms Jane Fisher, (Patient and Public Voice)
  • Dr Rosemary Fox, (Public Health Wales)
  • Dr Surendra Kumar, (Upton Medical Centre)
  • Dr Janet Little, (Public Health Agency Northern Ireland)


Vacancies for UK National Screening Committee members are published on the Department of Health (DH) website.


The UK NSC holds 3 meetings a year to review current decisions and make recommendations on screening programmes. Meetings are usually in February, June and October. They are held in London twice a year, with the June meeting hosted by one of other 3 UK Countries on a rotating basis.

The UK NSC will usually publish draft minutes and a summary of recommendations 4 weeks after the meeting.

Read recent UK NSC meeting minutes. For minutes from before 2015 please see the national archives website.

Read a complete list of UK NSC recommendations


The Fetal, Maternal and Child Health group (FMCH) advises the UK NSC on issues relating to screening policy in the relevant populations as well as provide a reference group for issues relating to the implementations and improvement of screening programmes. This includes cross cutting and programme specific issues.

Sub-committee membership

  • Dr Hilary Angwin, Chair (Public Health Consultant)
  • Dr Helen Bedford, (University College London)
  • Dr Jean Chapple, (Health Training Programme Director)
  • Dr David Elliman, (Great Ormond Street Hospital)
  • Ms Jane Fisher, (Antenatal Results and Choices)
  • Ms Mervi Jokinen, (Royal College of Midwives)
  • Dr Andrew Morris, (Central Manchester University Hospitals NHS Foundation Trust)
  • Mr Pranav Pandya, (University College London)
  • Dr Annie Procter, (Consultant in Medical Genetics)
  • Professor Basky Thilaganathan, (St Georges Hospital NHS Foundation Trust)

Terms of reference (under review)

The UK NSC will advise ministers and the NHS in all 4 UK countries about:

  • the case for implementing new population screening programmes not presently provided by the NHS within each of the countries in the UK
  • screening technologies of proven effectiveness but which require controlled and well-managed introduction
  • the case for continuing, modifying or withdrawing existing population screening programmes. In particular, programmes inadequately evaluated or of doubtful effectiveness, quality, or value
  • generic issues relating to screening programmes and policy

The UK NSC will call on sound evidence to inform its advice and recommendations. In particular:

  • calling on the advice of the Health Technology Assessment Programme’s Diagnostic Technologies and Screening Panel
  • discussing key research needs with the DH Policy Research Programme and the National Institute for Health Research (NIHR) in England as well as the Chief Scientist’s Office and Healthcare Improvement Scotland (the organisation which carries out Health Technology Assessments in Scotland)
  • calling on other and appropriate sources of sound evidence from within and outside the NHS, including having regard to the broad balance of benefits and costs, and the effective use of available resources

The UK NSC will agree standards for the new programmes, which can be used as a basis for discussion by the standard setting bodies in the other UK countries, as well as advise on their implementation in the NHS.

The UK NSC will be informed by reports from the Advisory Groups or committees for specific programmes in each country on the performance of those programmes and issues that arise which would have relevance to general screening policy.


Read UK NSC publications and statements.


NHS population screening helpdesk

Public Health England Zone B
Floor 2 Skipton House
80 London Road


The helpdesk and national programmes do not have access to screening results.

Parents: contact your midwife or health visitor for information on screening results.

Health professionals: contact the local screening team, screening laboratory or local child health records department.

UK National Screening Committee Secretariat

Floor 2, Zone B
Skipton House
80 London Road